Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
CSE Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

More stories below advertisement

Yield Growth Manufactures Hand Sanitizers & Prepares for Amazon Prime Sales

Newsfile Corp - Thu May 28, 5:02AM CDT

Vancouver, British Columbia--(Newsfile Corp. - May 28, 2020) - The Yield Growth Corp. (CNSX:BOSS.CN) (OTCQB:BOSQF) (FSE:YG3) announces that it has successfully completed its first manufacturing run of Urban Juve hand sanitizer spray and is now fulfilling retail and consumer pre-orders. This includes individual consumers, Canadian online retailers and brick and mortar retail stores such as Pharmasave.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/56727_img1.jpg

Yield Growth Manufactures Hand Sanitizers & Prepares for Amazon Prime Sales

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6377/56727_img2.jpg

The Ultra-Nourishing Hand Sanitizer spray is now available for sale at urbanjuve.com for immediate fulfillment. In addition, the spray has been approved for sale on Amazon.ca and Urban Juve is currently arranging its first shipment to the Canadian Amazon warehouse. Urban Juve's hand sanitizer is expected to be available for Amazon Prime members through Amazon.ca (Amazon Canada) within two weeks.

"We are excited about the opportunity to partner with leading retailers and distributors, like Amazon and Pharmasave, to put our premium hand sanitizer products into the hands of Canadian consumers," says Karla Cheon, Yield Growth's VP, Marketing. "Our sanitizer was thoughtfully formulated with high quality ingredients - no low grade fillers. This is an excellent introduction to Urban Juve for many customers, and allows us to build on the solid foundation of quality products."

Yield Growth's wholly owned subsidiary Urban Juve expects 100,000 more hand sanitizer gel units to be manufactured in July. These are for the Canadian and the U.S. market, and Urban Juve is now taking orders from retail chains, including Pharmasave, for these products.

Urban Juve received product licenses for three separate hand sanitizer products from Health Canada's Natural and Non-Prescription Health Products Directorate. In addition, Urban Juve's hand sanitizer gel has been approved for sale in the U.S. after successfully listing with the U.S. Food and Drug Administration.

The Urban Juve hand sanitizer gel contains 65% alcohol as well as Aloe Vera, which can help to reduce the side effects that many hand sanitizers cause such as dryness of the skin. It also contains Eucalyptus Oil, which helps improve dry skin by increasing its ceramide content. Urban Juve's natural hand sanitizer liquid spray contains 65% alcohol, as well as a refreshing and clean blend of peppermint, lavender and orange peel oils, which are known for their disinfecting properties and their ability to promote optimum skin health.

Urban Juve is donating a portion of the sanitizing sprays to aid front line workers at organizations such as PHS Community Services Society, St. Michael's Care Home and Magnolia House.

To combat Covid-19, the Centers for Disease Control and Prevention (CDC) recommends individuals use an alcohol-based hand sanitizer that contains at least 60% alcohol if soap and water are not readily available.

The hand sanitizer market is expected to grow at a CAGR of over 17% between 2019 and 2025 according to a new report from Aritzon, with sales this year expected to reach US $11 billion in 2020, a 600% increase over last year. Alcohol-based hand sanitizers are set to become a standard household good.

About The Yield Growth Corp.

The Yield Growth Corp. (CNSX:BOSS.CN),(OTCQB:BOSQF) is a phytoceutical and consumer packaged goods company that develops and acquires intellectual property and other assets related to plant-based products and therapeutics, and develops, manufactures, markets, sells and distributes plant-based products that improve lives. It owns and operates the brands Urban Juve (skin care and antiviral products), Wright & Well (a U.S. cannabis brand) and Jack n Jane (a Canadian cannabis brand), and has over 200 proprietary wellness formulas at various stages of commercialization. Its products are sold through e-commerce worldwide and retail stores in 3 countries with distribution agreements in place for 12 more countries. It has 14 patent applications filed in what the Global Wellness Institute reports is a $4.2 trillion-dollar global wellness market. Its majority owned subsidiary NeonMind Biosciences Inc. is launching a line of medicinal mushroom products and is engaged in preclinical studies to develop psychedelic medicine. The Yield Growth management team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, Skechers and Aritzia.

For more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram.

Investor Relations Contacts:

Penny White, President & CEO

Kevan Matheson, Investor Relations

invest @yieldgrowth.com

1-833-514- BOSS 1-833-514-2677

1-833-515- BOSS 1-833-515-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, "forward looking statements") under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies do to the spread of the Coronavirus, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company's products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/56727

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies